DXCM — DEXCOM INC

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in DEXCOM INC (DXCM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2024 Q4)
Avg. % of fund
0.05%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 3,254 -96,761 -96.7% 0.00% $219K $67.29
2024 Q4 INITIATED 100,015 — — 0.10% $7.8M $77.77
% of Fund (quarterly)    DXCM price (monthly, adj. close)

Other funds also holding DXCM

As of 2025 Q4 — sorted by position size

MIG Capital, LLC 3Y 7Y 6.82% BRIDGER MANAGEMENT, LLC 3Y 7Y 4.35% Parkman Healthcare Partners LLC 3Y 3.71% Tri Locum Partners LP 3Y 3.63% SIRIOS CAPITAL MANAGEMENT L P 3Y 7Y 3.56% Soleus Capital Management, L.P. 3Y 3.18% Vestal Point Capital, LP 2.88% Alphabet Inc. 3Y 2.67% Intermede Investment Partners Ltd 3Y 7Y 2.48% ELLERSON GROUP INC /ADV 3Y 2.4%
← Back to Freestone Grove Partners LP Holdings